Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 6, Issue 4, pp. 467-480
PubMed
Published By
Print ISSN
Online ISSN
History
- Received April 19, 2017
- Revision received November 13, 2017
- Accepted February 1, 2018
- Published first February 19, 2018.
Article Versions
- Previous version (February 19, 2018 - 09:52).
- Previous version (March 12, 2018 - 07:37).
- You are viewing the most recent version of this article.
Copyright & Usage
©2018 American Association for Cancer Research.
Author Information
- Vincent Yi Sheng Oei1,2,
- Marta Siernicka3,4,
- Agnieszka Graczyk-Jarzynka3,
- Hanna Julie Hoel1,
- Weiwen Yang1,
- Daniel Palacios1,2,
- Hilde Almåsbak1,
- Malgorzata Bajor3,
- Dennis Clement1,2,
- Ludwig Brandt5,
- Björn Önfelt5,6,
- Jodie Goodridge1,2,
- Magdalena Winiarska3,
- Radoslaw Zagozdzon3,7,
- Johanna Olweus1,2,
- Jon-Amund Kyte1,8, and
- Karl-Johan Malmberg1,2,9,*
- 1Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Norway.
- 2The KG Jebsen Centre for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
- 3Department of Immunology, Centre for Biostructure Research, Medical University of Warsaw, Warsaw, Poland.
- 4Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland.
- 5Science for Life Laboratory, Department of Applied Physics, KTH–Royal Institute of Technology, Solna, Sweden.
- 6Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
- 7Department of Clinical Immunology, Transplantation Institute, Medical University of Warsaw, Warsaw, Poland.
- 8Department of Oncology, Oslo University Hospital, Oslo, Norway.
- 9Centre for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
- ↵*Corresponding Author:
Karl-Johan Malmberg, Oslo University Hospital, Ullernchausseen 70, 0310 OSLO, Phone: 47-45390926; E-mail: k.j.malmberg{at}medisin.uio.no